SAN DIEGO, Jan. 13, 2017 /PRNewswire/ — Medical Marijuana, Inc. (MJNA) announced today that its subsidiary, Kannaway LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is holding an exclusive Red Carpet Event in Atlanta, Ga., this weekend. The Red Carpet event provides a unique opportunity to network with top Kannaway leaders, the company’s executive team and fellow Kannaway business owners.
Attendees will hear from several executive team members, including Kannaway CEO Blake Schroeder, President Brad Tayles and CEO of Kannaway parent company Medical Marijuana, Inc., Dr. Stuart Titus. Additionally, the company will reveal important additions to the Kannaway brand, exciting changes to the incentive program and compensation plan and launch a new CBD Lifestyle Challenge.
“We are always excited to host our Kannaway Red Carpet Events as it is a chance for everyone to come together and learn more about the Kannaway system and immense possibilities afforded by being part of the Kannaway business,” Kannaway CEO Blake Schroeder said. “As the first Red Carpet Event in 2017, we will not only be providing exclusive pricing on our newly revamped products, but we will also be launching a new and improved formulation of one of our most popular CBD hemp oil products.”
The Atlanta Red Carpet Event is scheduled from 1 pm to 4 pm on Saturday, Jan. 14. Advance tickets to the Atlanta Red Carpet Event are available now for just $30. The day of the event, the price of tickets will increase to $40 at the door.
Prior to the Red Carpet Event, Kannaway will host a Business Opportunity Meeting. This meeting will run from 11:30 am to 12:30 pm the day of the show. There is no charge for this portion of the event, and interested prospects who attend can choose to buy a ticket to the ensuing Red Carpet Event.
About Kannaway, LLC
Kannaway, LLC, is a network sales and marketing company specializing in the sales and marketing of hemp-based botanical products. Kannaway currently hosts weekly online sales meetings and conferences across the United States, offering unique insight and opportunity to sales professionals who are desirous of becoming successful leaders in the sale and marketing of hemp-based botanical products.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.